Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020)
Ovid Therapeutics (OVID) posted Non Operating Income of $590491.0 for Q2 2020, up 123.42% on a QoQ basis from $264296.0 in Q1 2020, and up 122.83% year-over-year from $264999.0 in Q3 2019.
Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020) Analysis & Trends
Ovid Therapeutics' Non Operating Income history runs 5 years deep, the most recent figure standing at $590491.0 for Q2 2020.
- Quarterly Non Operating Income rose 122.83% year-over-year to $590491.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $1.3 million (up 35.48% YoY) and the FY2019 annual result came in at $948224.0, changed 0.4% from the prior year.
- Non Operating Income was $590491.0 for Q2 2020 at Ovid Therapeutics, up from $264296.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $590491.0 in Q2 2020 and bottomed at $23000.0 in Q1 2017.
- A 5-year average of $170951.4 and a median of $172500.0 in 2018 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2018 — Non Operating Income surged 973.91% — and 2019, when it plunged 38.79%.
- Ovid Therapeutics' Non Operating Income stood at $27000.0 in 2016, then jumped by 225.93% to $88000.0 in 2017, then surged by 145.45% to $216000.0 in 2018, then jumped by 38.43% to $299000.0 in 2019, then surged by 97.49% to $590491.0 in 2020.
- Business Quant data shows OVID's Non Operating Income at $590491.0 in Q2 2020, $264296.0 in Q1 2020, and $299000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Ovid Therapeutics | 121.66 Mn | -33.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 590,491.00 |
| Mar 31, 2020 | 264,296.00 |
| Dec 31, 2019 | 299,000.00 |
| Sep 30, 2019 | 131,000.00 |
| Jun 30, 2019 | 264,999.00 |
| Mar 31, 2019 | 253,340.00 |
| Dec 31, 2018 | 216,000.00 |
| Sep 30, 2018 | 214,000.00 |
| Jun 30, 2018 | 275,000.00 |
| Mar 31, 2018 | 247,000.00 |
| Dec 31, 2017 | 88,000.00 |
| Sep 30, 2017 | 51,000.00 |
| Jun 30, 2017 | 40,000.00 |
| Mar 31, 2017 | 23,000.00 |
| Dec 31, 2016 | 27,000.00 |
| Sep 30, 2016 | 30,000.00 |
| Jun 30, 2016 | 31,000.00 |
| Mar 31, 2016 | 32,000.00 |